Home

Christopher R. Cline, CFO: Travere Therapeutics TVTX Sell · Filed 25/08/28

Trade details

Type
Insider sale
Amount
$8,135.7
Shares · price
470 sh · $17.31 a share
Held after
92,656 sh
Trade date
25/08/27
Filed
25/08/28
Days to filing
1 days

Sold 0.5% of holdings

Share of holding sold
0.5%

Travere Therapeutics trades, last 26 weeks

What else happened in Travere Therapeutics around then

Filed or reported within 30 days of the trade day · 25/07/28~25/09/26

Christopher R. Cline's recent trades

  • Christopher R. Cline

    Planned sale10b5-1 planTravere Therapeutics

    $3.3M

    Filed 09/15

  • Christopher R. Cline

    Sell10b5-1 planTravere Therapeutics

    $101.7K

    Filed 05/06

  • Christopher R. Cline

    Sell10b5-1 planTravere Therapeutics

    $13.6K

    Filed 05/06

  • Christopher R. Cline

    Planned sale10b5-1 planTravere Therapeutics

    $13.6K

    Filed 05/06

  • Christopher R. Cline

    Planned saleTravere Therapeutics

    $101.7K

    Filed 05/05